Teucrium Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Teucrium Investment Advisors's LLY Position: Q2 2026 in Review
Teucrium Investment Advisors reduced its Eli Lilly (LLY) stake by 39% in Q2 2026, selling an estimated $444K and leaving 688 shares worth $825K. The position accounts for 0.73% of the portfolio, ranked #28.
Teucrium Investment Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.6M in Q4 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Teucrium Investment Advisors held 688 shares of Eli Lilly worth $825K as of Q2 2026.
- Teucrium Investment Advisors sold 435 Eli Lilly shares in Q2 2026, an estimated $444K.
- Eli Lilly made up 0.73% of Teucrium Investment Advisors's portfolio in Q2 2026, its #28 holding.
- Teucrium Investment Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- Teucrium Investment Advisors's Eli Lilly position peaked at $1.6M in Q4 2025.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Teucrium Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.